VICL (Vical Labs) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VICL (Vical Labs)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: William Strop who wrote (281)	6/24/1997 10:49:00 PM
From: William Strop	of 1972

All, A question to ponder.... When reading the special report re: Gene Therapy in the June/1997 issue of Scientific American, I came across a stated 'ultimate goal' of gene delivery systems. It was stated, "Our ultimate goal, of course, is to deliver vectors into the bloodstream or other sites and to have them act like homing pigeons, finding their own way to the desired cells -- say, to organs that are hard to reach or to hidden cancer deposits. No such targeted carriers are yet ready for testing in patients, but work toward that end is advancing quickly". So, is Vical on course toward the 'ultimate goal'??? Is some other company closer to the 'ultimate goal'??? Bill

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next